SPAZZOLINI, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 364
AS - Asia 239
EU - Europa 233
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 844
Nazione #
US - Stati Uniti d'America 358
CN - Cina 204
IE - Irlanda 105
FI - Finlandia 54
DE - Germania 29
SG - Singapore 24
UA - Ucraina 19
IT - Italia 7
CA - Canada 6
BR - Brasile 4
FR - Francia 3
HK - Hong Kong 3
JP - Giappone 3
RU - Federazione Russa 3
CH - Svizzera 2
GB - Regno Unito 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
SE - Svezia 2
BD - Bangladesh 1
BE - Belgio 1
BG - Bulgaria 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
IN - India 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NO - Norvegia 1
Totale 844
Città #
Dublin 105
Chandler 91
Nanjing 49
Jacksonville 40
Beijing 36
Ashburn 35
Helsinki 33
Nanchang 20
Wilmington 19
Boardman 18
Changsha 18
Princeton 18
Lawrence 16
Shenyang 15
Shanghai 13
Jiaxing 12
Medford 11
Singapore 11
Hangzhou 8
Hebei 6
Tianjin 6
Toronto 6
Los Angeles 5
Falkenstein 4
Falls Church 3
Hong Kong 3
Norwalk 3
Ann Arbor 2
Auckland 2
Chicago 2
Milan 2
New York 2
Nuremberg 2
Orange 2
Pavia 2
Riga 2
San Francisco 2
Seattle 2
São Paulo 2
Tokyo 2
Zhengzhou 2
Zurich 2
Amman 1
Athens 1
Bishkek 1
Borås 1
Brussels 1
Chengdu 1
Clifton 1
Des Moines 1
Dhaka 1
Fairfield 1
Foshan 1
Guayaquil 1
Indaiatuba 1
Jinan 1
Kavir 1
Kunming 1
Luxembourg 1
Milton Keynes 1
Moscow 1
Newark 1
Oslo 1
Porto Ferreira 1
Pune 1
San Genesio Ed Uniti 1
Simi Valley 1
Sofia 1
Verona 1
Walnut 1
Wuhu 1
Totale 663
Nome #
Risk stratification in the Long-QT Syndrome 81
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 71
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 63
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 60
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 59
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 59
The genetics underlying acquired long QT syndrome: impact for genetic screening. 57
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 55
Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists. 48
Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?" 48
Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease. 47
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 46
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 46
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 46
Cost-effectiveness of neonatal ECG screening for the long QT syndrome 43
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. 42
Totale 871
Categoria #
all - tutte 4.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 0 0 0 0 17 24 0
2020/202140 6 3 0 3 0 4 0 13 1 7 3 0
2021/202264 0 0 6 0 2 2 0 6 1 0 11 36
2022/2023262 38 20 11 10 19 22 0 14 119 2 6 1
2023/2024102 8 23 2 7 8 18 3 15 2 7 1 8
2024/2025124 9 16 1 3 7 32 6 28 22 0 0 0
Totale 871